Departments of Medicine and Pathology, Marion Bessin Liver Research Center, Diabetes Center, Cancer Center, Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Institute for Clinical and Translational Research, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Lab Invest. 2018 Apr;98(4):525-536. doi: 10.1038/s41374-017-0010-7. Epub 2018 Jan 19.
Hepatic stellate cells (HSCs) are major contributors to liver fibrosis, as hepatic injuries may cause their transdifferentiation into myofibroblast-like cells capable of producing excessive extracellular matrix proteins. Also, HSCs can modulate engraftment of transplanted hepatocytes and contribute to liver regeneration. Therefore, understanding the biology of human HSCs (hHSCs) is important, but effective methods have not been available to address their fate in vivo. To investigate whether HSCs could engraft and repopulate the liver, we transplanted GFP-transduced immortalized hHSCs into immunodeficient NOD/SCID mice. Biodistribution analysis with radiolabeled hHSCs showed that after intrasplenic injection, the majority of transplanted cells rapidly translocated to the liver. GFP-immunohistochemistry demonstrated that transplanted hHSCs engrafted alongside hepatic sinusoids. Prior permeabilization of the sinusoidal endothelial layer with monocrotaline enhanced engraftment of hHSCs. Transplanted hHSCs remained engrafted without relevant proliferation in the healthy liver. However, after CCl or bile duct ligation-induced liver damage, transplanted hHSCs expanded and contributed to extracellular matrix production, formation of bridging cell-septae and cirrhosis-like hepatic pseudolobules. CCl-induced injury recruited hHSCs mainly to zone 3, whereas after bile duct ligation, hHSCs were mainly in zone 1 of the liver lobule. Transplanted hHSCs neither transdifferentiated into other cell types nor formed tumors in these settings. In conclusion, a humanized mouse model was generated by transplanting hHSCs, which proliferated during hepatic injury and inflammation, and contributed to liver fibrosis. The ability to repopulate the liver with transplanted hHSCs will be particularly significant for mechanistic studies of cell-cell interactions and fibrogenesis within the liver.
肝星状细胞(HSCs)是肝纤维化的主要贡献者,因为肝损伤可能导致它们转分化为肌成纤维细胞样细胞,能够产生过多的细胞外基质蛋白。此外,HSCs 可以调节移植肝细胞的植入,并有助于肝再生。因此,了解人 HSCs(hHSCs)的生物学特性非常重要,但目前还没有有效的方法来解决其在体内的命运问题。为了研究 HSCs 是否能够植入和重新 populate 肝脏,我们将 GFP 转导的永生化 hHSCs 移植到免疫缺陷的 NOD/SCID 小鼠中。用放射性标记的 hHSCs 进行的生物分布分析表明,脾内注射后,大多数移植细胞迅速转移到肝脏。GFP 免疫组织化学显示,移植的 hHSCs 与肝窦毗邻植入。预先用单环素来破坏窦内皮层可增强 hHSCs 的植入。在健康的肝脏中,移植的 hHSCs 保持植入而没有明显增殖。然而,在 CCl 或胆管结扎诱导的肝损伤后,移植的 hHSCs 扩增并有助于细胞外基质的产生、桥接细胞隔的形成和类似肝硬化的肝假小叶。CCl 诱导的损伤主要将 hHSCs 募集到 3 区,而在胆管结扎后,hHSCs 主要在肝小叶的 1 区。在这些情况下,移植的 hHSCs 既没有向其他细胞类型转分化,也没有形成肿瘤。总之,通过移植 hHSCs 生成了一种人源化小鼠模型,这些细胞在肝损伤和炎症期间增殖,并有助于肝纤维化。用移植的 hHSCs 重新 populate 肝脏的能力对于研究细胞-细胞相互作用和肝内纤维化的机制将具有特别重要的意义。